Clinical Trial Update: Expiratory Muscle Training for Persons With Neurodegenerative Disease [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial of Expiratory Muscle Training in people with Parkinson's disease and multiple sclerosis has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Parkinson Disease

Snippet

Sponsor: VA Office of Research and Development | Conditions: Parkinson's Disease, Multiple Sclerosis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-11-29